The pharmaceutical industry constantly seeks more efficient and selective methods for synthesizing complex drug molecules. At the heart of many of these processes are specialized chemical reagents that enable precise transformations. Lithium Tri-tert-butoxyaluminum Hydride (LTBA), with its CAS number 17476-04-9, has emerged as a vital player, offering a unique combination of mildness and selectivity that is highly prized in API development. For R&D scientists and procurement managers looking to buy high-quality pharmaceutical intermediates, understanding LTBA's capabilities is essential.
The Role of LTBA in API Synthesis
As a reducing agent, LTBA (C12H28AlLiO3) is less prone to over-reduction than stronger hydrides like LiAlH4. This characteristic is particularly advantageous in multi-step pharmaceutical syntheses where preserving sensitive functional groups is critical. For instance, LTBA can selectively reduce carbonyl groups in aldehydes and ketones to alcohols without affecting ester or nitrile functionalities present in precursor molecules. This makes it an ideal choice for building complex molecular architectures required for modern pharmaceuticals. Pharmaceutical formulation often demands extreme purity, and sourcing intermediates like LTBA from reputable manufacturers ensures that your synthetic routes remain robust and compliant.
Advantages for Pharmaceutical R&D and Production
The benefits of incorporating LTBA into pharmaceutical synthesis workflows are manifold:
When exploring options to buy chemical reagents for your pharmaceutical projects, considering the source is as important as the product itself. We provide comprehensive product information, including detailed specifications and competitive pricing, to support your decision-making process.
Procurement Insights for Pharmaceutical Intermediates
Procurement managers within the pharmaceutical sector often face the challenge of balancing cost, quality, and supply reliability. By partnering with established manufacturers like us, you gain access to high-purity Lithium Tri-tert-butoxyaluminum Hydride (CAS 17476-04-9) at competitive prices. Our commitment to stringent quality control and efficient manufacturing processes ensures that we meet the demanding standards of the pharmaceutical industry. We encourage you to reach out for samples or to discuss your specific requirements for this essential chemical intermediate.
For detailed pricing, availability, and technical assistance regarding Lithium Tri-tert-butoxyaluminum Hydride, please contact our sales team. We are dedicated to supporting your pharmaceutical research and manufacturing endeavors with premium chemical solutions.
Manufacturing Facilities






Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.